Kayne Anderson Rudnick Investment Management LLC Exact Sciences Corp Transaction History
Kayne Anderson Rudnick Investment Management LLC
- $43.7 Billion
- Q3 2024
A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 200 shares of EXAS stock, worth $11,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$11,420
Previous $8,000
62.5%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EXAS
# of Institutions
676Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.01 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$905 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$818 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$689 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$381 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.1B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...